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CHAPTER 1
 
INTRODUCTION
 
Recent advances in DNA vaccine technology has brought about a promising 
strategy for the control of viruses that contain surface membrane glycoproteins. This type 
of vaccine involves the intramuscular injection of a bacterial plasmid containing a gene 
encoding a viral protein. The strategy uses eukaryotic processing of the protein as would 
naturally occur during a viral infection. 
Our lab has developed a glycoprotein based DNA vaccine for rainbow trout 
against infectious hematopoietic necrosis virus (IHNV) (Anderson, E.D. et a1.1996). The 
vaccine is composed of the bacterial plasmid pcDNA3 and the complete gene sequence 
for the glycoprotein of IHNV. As would occur during a normal viral infection, the 
glycoproteins are synthesized and incorporated into the plasma membrane. Part of the 
glycoprotein projects out of the infected cell, appearing as spikes observed through 
electron microscopy. 
Immunization experiments with this DNA vaccine followed by IHNV challenge 
produced relative survival rates of 75 percent or greater, even in fish as small as 0.3-0.4 g 
average weight (Anderson, E.D. et a/.1996). These findings were very encouraging and 
we assumed that protection was based on neutralizing antibodies specific for IHNV. 
However, studies within the last decade in mammalian systems have shown that viral 2 
glycoproteins can stimulate the production of interferon which could be the basis for the 
protection (Ito, Y. 1994; Ito, Y. et al. 1994; Ito, Y. & Y. Hosaka, 1983). The results of the 
mammalian studies led to a model where viral glycoproteins, in general, can act as 
mitogens to stimulate lymphoid cells into producing interferon and subsequently leading 
to non-specific protection. This stimulation is based on a membrane-membrane 
interaction between lymphoid cells and cells containing the protruding transmembrane 
glycoproteins. 
On the basis of this model, we sought to examine the specificity of the IHNV 
response induced by the IHNV DNA vaccine by treating fish with several different 
plasmid vectors containing glycoprotein genes from different rhabdoviruses. In this 
study, we present evidence that glycoprotein-based DNA vaccines induce an immune 
response that protects trout through production of non-specific factors. All of the 
glycoprotein vaccines in the test group provided protection against IHNV infection. 
Plasmid DNA encoding the glycoproteins of IHNV (pcDNA3-IHNV-g), SHRV 
(pcDNA3-SHRV-g), or SVCV (pcDNA3-SVCV-g) was injected into the skeletal muscle 
of rainbow trout fry. After 30 days, the fish were challenged with IHNV. Results clearly 
indicated that the glycoproteins of these different viruses all induced a protective immune 
response in fish. The mechanisms for the viral mediated resistance induced by these DNA 
vaccines is unknown, but a parallel study conducted by Dr. Carol Kim, who examined the 
production of Mx proteins in these fish, suggests that the protection observed might be a 
consequence of the stimulation of interferon. 3 
CHAPTER 2
 
LITERATURE REVIEW
 
Rainbow trout, Oncorhynchus mykiss, is a member of the family Salmonidae and 
is an important aquaculture food product worldwide. Europe, Japan, South America, and 
the United States are the major producers of farmed reared trout (Parsons, J. 1998). In 
1997, the United State Department of Agriculture reported $78 million worth of trout 
sold (Aquaculture Magazine Buyer's Guide 1998). There are 18 states that commercially 
farm trout and in 1997, Idaho was the leading producer with 75% of the United States 
production (Trout Production report, 1997) 
The success of trout farming can be attributed to the ease in which trout can be 
cultured in a variety of captive environments. But as in any situation where animals are 
placed in high-density regimes, susceptibility to infectious diseases is a devastating 
problem. In the United States, approximately 5 million pounds of trout during 1997 were 
lost to disease (Aquaculture Magazine Buyer's Guide 1998). Clearly, the trout industry 
must develop control strategies for disease at trout rearing facilities. Efforts to develop 
an understanding of the trout immune system and to use this understanding to develop 
better vaccines are important for the industry. 
DNA Vaccines for Fish Aquaculture 
The goal of any vaccine is the stimulation of an immune response that resolves 
infection and provides long lasting protection. In mammals, this primarily involves the 
activity of B and T lymphocytes and subsequently, the production of antibodies (humoral 4 
response). In addition, vaccines prime immune cells such as cytotoxic T lymphocytes, 
natural killer cells, and macrophages (cellular response). 
For the past 100 years, vaccine development has been limited to vaccines 
consisting of live-attenuated virus, killed virus, or purified viral protein (subunit 
vaccines). Most recently, advancements in vaccine technology introduced the DNA 
vaccine. This type of vaccine involves the intramuscular injection of a bacterial plasmid 
containing a gene of an appropriate viral protein. This strategy enables eukaryotic 
processing of the protein as would naturally occur during a viral infection. The advantage 
of DNA vaccines is the stimulation of both humoral and cellular immune responses 
(Donnelly, J.J. et al. 1997). DNA vaccines not only induce the production of antibodies 
but also stimulate cytotoxic T cells and helper T cells, which can be regarded as 
necessary components of a truly effective vaccine (Leung, K.N. & Ada, G.L. 1982; 
Taylor, P.M. & Askonas, B.A. 1986). 
With regard to fish aquaculture, the ability of a vaccine to provide protection is 
not sufficient. Other factors such as route of administration, protection against 
heterologous strains, safety, and expense contribute to the difficulties in the development 
of effective vaccines for high-density fish farming. Cost effectiveness is the number one 
issue. Typically, the production of a viral vaccine is expensive and any requirement for 
the administration of the vaccine to individual fish can dramatically heighten costs to the 
fish farmer. In many cases, the expense of replacing the diseased fish is less costly than 
administrating a vaccine. 
If DNA vaccines are to become a viable alternative in aquaculture it is necessary 
to overcome the cumbersome task of individual inoculations, which is labor intensive and 5 
difficult to administer to small fish. Although laboratory experiments show that DNA 
vaccines are very effective and rather inexpensive to produce, unless an easy vaccination 
procedure is developed, the adoption of a fish DNA vaccine is uncertain. 
Fish Immune System 
Our understanding of the immune system in fish is not as extensive as it is for the 
mammalian immune system. Nevertheless, we can point out the important differences 
between the immune response in fish versus mammals. One of the most conspicuous 
differences is the tissue location of the progenitor cells. In mammals, all of the cellular 
elements of blood arise from hematopoietic stem cells in the bone marrow. There is no 
bone marrow in fish and the hematopoietic stem cells are believed to reside in the 
anterior portion of the kidney. Also, fish do not possess lymph nodes. The spleen, liver, 
and kidneys are the primary organs in fish where substances are eliminated from the 
blood. Regardless of this difference, the immune components in the circulating blood of 
fish are basically the same as in mammals. Granulocytes and macrophages are present in 
fish and function in a similar manner. In addition, fish contain sub-populations of "1­
and "B" lymphocytes, although specific markers for these distinct cell types have not 
been identified. Components of the non-specific defense system such as complement and 
interferon have also been described in fish. These components appear to perform the 
equivalent functions as those described in mammals. 6 
Fish Antibody 
In comparison to mammals, the fish acquired immune response is quite restricted. 
Fish do produce an antigen-specific antibody response; however, the response is directed 
towards fewer epitopes on complex molecules and there does not seem to be a 
progression in the antibody response to yield antibodies with tighter binding affinities. 
There appears to be a secondary antibody response in fish, which would confirm the 
presence of memory cells (Kaattari, S.L. 1994). The magnitude of the secondary response 
is not logarithmic and is dramatically lower than in mammals There is also no 
substantive evidence for isotype switching. (Lobb & Olson, 1988; Killie et al., 1991) 
The absence of affinity maturation is striking and may be due, in part, to the fact that fish 
only produce a single class of tetrameric IgM like immunoglobulin. The humoral 
response in fish is also considerably slower than in mammals and is temperature 
dependent. 
Within the last decade, researchers have identified the cDNA sequences for 
major histocompatibility complex (MHC) class II 13, class II a, and 132 microglobulin 
(132m) genes in teleost fish (Godwin, U.B. et al.  1997; Antao, A.B. et al. 1997). 
Additional studies have detected 132m on periphereal blood lymphocytes (PBL) as well as 
on clonal B and T cell lines of catfish (Antao, A.B. et al. 1997). Also, the T cell receptor 
in teleost fish has been described (Hordvik, I. et al. 1996). These discoveries would 
indicate that although there are some structural differences in the components of the fish 
immune system, the function and immunological pathways leading to protection are 
similar to that in the mammalian system. 7 
Fish Cellular Immune Response 
The key cells in the non-specific cellular immune response in fish are 
granulocytes and monocytes/macrophages. In mammals, granulocytes are comprised of 
three distinct cell types: eosinophils, neutrophils, and basophils. Neutrophils are present 
in teleost fish, but whether the other two cell types are present has not been clearly 
determined (Ellis, A.E. 1977; Ainsworth, A.J. 1992). The functional role of mammalian 
macrophages is the elimination of invading microorganisms by phagocytosis, and this 
role is no different in fish. These macrophages are located in most tissues and are present 
as monocytes in circulating blood. Macrophages also play an enormous role in the 
specific cellular response by regulating T and B cell function (Seljelid R. & T. Eskeland, 
1993). One population of cells that are regulated by macrophage activity is the cytotoxic 
T cells. These cells are involved in killing targeted cells in a specific manner by 
recognizing antigen in the context of MHC class I. Even though these cells have been 
well documented in fish, the nature and development of these cells is undefined because 
of the difficulties in efficiently thymectomizing fish at early developmental stages 
(Partula, S et al. 1995). 
Interferon 
The host responds in many ways to a virus infection. One response is the 
production of interferons (IFN). Interferon are proteins that inhibit virus replication by 
inducing a series of antiviral and other proteins which can block the spread of virus to 
uninfected cells by controlling cellular regulation (White, D. 1994) (Janeway, C. 1996). 8 
The interferon released from a virus-infected cell binds to specific receptors on the 
plasma membrane of neighboring cells and its original host cell and up-regulates the 
expression of over 20 cellular genes called interferon-regulated proteins. These proteins 
can directly or indirectly interfere with viral replication. In mammals, there are two types 
of interferon (Stewart, W.E. 1980). Both function in a similar manner, but are structurally 
and genetically dissimilar and bind to different receptors. Type I interferons includes 
IFN-a and IFN-13. These interferons are produced by leukocytes and fibroblasts 
(Alexander, J.B. and G.A. Ingram 1992). Type II interferon is called IFN-y and is 
produced by T-lymphocytes (Kiener, P.A. & Spitalny, G.L. 1987). This type of 
interferon, which is considered a cytokine, activates immune cells such as natural killer 
cells and macrophages. IFN-y is also known to control the expression of MHC class I and 
class II genes and was discovered to be a macrophage activating factor, (MAF) 
(Alexander, J.B. & Ingram, G.A. 1992). 
Even though the gene for any interferon protein has not been successfully cloned 
from fish, there have been many studies indicating that fish cells have interferon activity. 
The first demonstration of interferon activity in fish was shown in 1965 when Gravell and 
Malsberger observed the inability of infectious pancreatic necrosis virus to replicate in a 
fathead minnow (Pimephales promelas) culture cell line (Gravell, M. & Malsberger, R.S. 
1965). Many other studies have been conducted on rainbow trout that were 
experimentally infected with viral hemorrhagic septicemia virus (VHSV) (De Kinkelin, 
P. & Dorson, M. 1973; Dorson, M. et al. 1975) and on rainbow trout cell lines (DeSena, 
J. & Rio, G.J., 1975; Okamoto, N. et al. 1983; Graham, S. & Secombest, C.T. 1988). 9 
It has not been possible to precisely determine what types of interferons are 
produced by fish. DNA hybridization experiments using probes from human DNA 
interferons suggest that fish possess IFN-p but not necessarily IFN-a (Wilson, V. et al. 
1983). Also, experiments using rainbow trout leukocytes stimulated with the mitogen 
concanavalin A secrete a soluble MAF which is characteristic of IFN-y (Graham, S. & 
Secombes, C.J. 1990). Until a fish interferon gene is cloned, there can be no definitive 
statement on fish interferons. 
Viral Pathogens 
In 1898, Martinus Beijerinck, who repeated the experiments of Dimitrii 
Ivanovsky, showed that a filterable agent separable from bacteria could cause disease, 
and introduced the term "virus". Since that first discovery, the number of viruses that 
have been described has increased. The viruses have since been classified into two main 
groups, DNA and RNA viruses. Viruses have been discovered and isolated from infected 
hosts of every Kingdom, and have been shown to infect nearly every cell type within 
multi-cellular organisms. In the late 1950's it was discovered that viruses were important 
pathogens of fish, and IHNV and IPNV were described. Since then, over 75 different 
viruses that infect fish have been isolated and partially characterized. Of these, one 
important family is Rhabdoviridae. 10 
Taxonomy 
The family Rhabdoviridae is comprised of viruses that infect invertebrates, plants, 
and animals Included in the family is an important human pathogen, rabies. The 
taxonomic structure of the family consists of 5 genera: Vesiculovirus (Vesicular 
stomatitis virus), Lyssavirus (Rabies serogroup), Ephemerovirus, Cytorhabdovirus, 
Nucleorhabdovirus, and a newly designated genus, Novirhabdovirus. The classification 
is based on serological cross reactivity and N gene similarity. 
Rhabdoviruses of fish 
Infectious hematopoietic necrosis virus (IHNV), Spring viremia of carp virus 
(SVCV), Viral hemorragic septicemia virus (VHSV), Hirame rhabdovirus (HIRRV), and 
Snakehead rhabdovirus (SHRV) are the only fish rhabdoviruses for which sequence 
information is available. 
Previously, SVCV had been considered as most closely related to vesiculoviruses 
and VHSV and IHNV as most closely related to lyssaviruses (Hill, B.J. 1975). More 
recent studies comparing the glycoprotein sequence from SVCV, IHNV, VHSV, and 
HIRRV with other rhabdoviruses indicated that the relationships might be different. 
While SVCV is more closely related to vesiculoviruses, the other three fish rhabdoviruses 
are most closely related to each other and do not group with any of the mammalian virus 
glycoprotein genes (Bjorkland, H.V. et al. 1996). This and other genetic similarities 
based on the NV gene have led the Rhabdoviridae study group to petition the 
International Committee on the Taxonomy of Viruses (ICTV) for the adoption of a new 11 
genus, Novirhabdovirus (Walker, P. 1998). The genus will contain HIRRV, IHNV, and 
VHSV, and the prototypic member will be IHNV. 
Genomic Structure 
A rhabdovirus virion contains a single-stranded, negative sense RNA genome that 
makes up approximately 2% of the virion weight. The genome typically encodes five 
structural proteins: nucleoprotein (N), polymerase (L), phoshoprotein (P), matrix protein 
(M), and glycoprotein (G). However, there are several genera in the family 
Rhabdoviridae that have genomes encoding six and seven genes (Bjorkland, H.V. et al. 
1996). IHNV, for example, contains an additional gene that encodes a nonstructural 
protein (NV) whose function remains unknown. Similarly, the Ephemeroviruses also 
contain an additional gene, which is nonfunctional. 
Morphology 
The virion of most rhabdoviruses has an average size of 170 x 70nm and a distinct 
bullet shape morphology that is hemispherical at one end and planar at the other end. 
The virion is enclosed by a lipid bilayer envelope, which is obtained when the virus buds 
through the plasma membrane of the infected host cell. Glycoprotein peplomexs 
surround the helical wound nucleocapsid and protrude through the lipid envelope. The 
matrix proteins are located on the inner side of the envelope and have been shown to 
interact with both the N and G proteins. 12 
Infectious hematopoietic necrosis virus 
IHNV is a viral pathogen of salmonid fishes. It is enzootic to Western North 
America but has spread throughout countries of the Northern Pacific Rim and Europe by 
the movement of infected fish and eggs (Winton, J.R. 1991). Young fish are the most 
susceptible to disease and resistance increases with age, where adults tend to be lifelong 
carriers. Extensive mortality is seen in hatchery reared fry where losses due to disease 
can exceed 90% (Leong, J.C.  et al. 1988). 
The first report of this viral disease was in 1953 in sockeye salmon 
(Oncorhynchus nerka) at two fish hatcheries in the state of Washington, USA (Rucker, 
R.R. et al. 1953). In 1958, a similar viral disease was isolated from juvenile sockeye 
salmon at the Oakridge Salmon Hatchery, Oregon. The virus was propagated in cell 
culture and was given the name Oregon Sockeye Virus (OSV). In the same year, chinook 
salmon (Oncorhynchus tshawytscha) fry at hatcheries along the Sacramento River in 
California were infected with a similar viral disease and was named Sacramento River 
Chinook Disease (Ross, A.J. et al. 1960; Parisot, T.J. & J. Pelnar 1962). Finally in 1967, 
rainbow trout and sockeye salmon in British Columbia, Canada were reported to have a 
viral disease, which revealed extensive necrosis of the hematopoietic tissue of the 
anterior kidney and spleen. This disease was named infectious hematopoietic necrosis 
disease (Amend, D.F.  et al.  1969). The viruses isolated from all of these geographic 
regions showed the same bullet shape morphology as seen by electron microscopy, the 
same mortality rate and pathology in diseased fish, and the same cytopathic effect on 
cultured cell lines. It was proposed that the same virus caused these geographically 
distinct diseases and Amend and Chambers declared the common name, IHNV, inl 970. 13 
Salmonids Susceptible to IHNV are sockeye salmon, chinook salmon, rainbow/ 
steelhead trout and Atlantic salmon (Salmo salar), while coho salmon (Oncorhynchus 
kisutch) appear to be resistant (Fryer, J.L. et al. 1996). Brown trout (Salmo trutta) and 
cutthroat trout (Oncorhynchus clarki) have been experimentally infected. The route of 
infection is probably through the gills, skin, (Yamamato et al. 1992; Drolet et al. 1995; 
Lapatra et al. 1989) and gastrointestinal tract. Transmission of IHNV occurs both 
horizontally and vertically. Traxler in 1993, demonstrated transmission in water from 
infected spawning adults to uninfected fry. Also, IHNV has been demonstrated to have 
high affinity binding for salmon sperm (Mulcahy, D. & R.J. Pascho, 1984) and that 
IHNV-infected cells are present in the ovarian fluid (Mulcahy & W.N. Batts, 1987). 
Like most virus diseases, there is a characteristic pathology. External clinical 
signs of disease include abdominal distention, exopthalmia, and darkened coloration of 
the body, hemorrhaging throughout the musculature and at the base of fins, fecal casts, 
and lethargy. Internally, the liver, spleen, and kidney appear pale and the stomach and 
intestine are filled with a milky or watery fluid (Fryer, J.L et al. 1996) 
Spring viremia of carp 
Spring viremia of carp (SVC) is a disease among cultured cyprinid fishes. The 
virus Rhabdovirus carpio or more commonly referred to in the literature as SVC virus 
(SVCV) causes this disease. The disease is most serious in Europe and the Soviet 
Republics where cyprinid aquaculture is intense. Carps are the primary fishes that are 
infected. This includes crucian carp (Carassius carassius), grass carp (Ctenopharyngon 
idella), bighead carp (Hypophthalmichthys molitrix), and silver carp (Aristichthys nobilis) 14 
(Fijan, N. 1993). Natural infection and subsequent mortality have also been observed in 
other fish such as the fry of sheatfish (Silurus glanis). Also, experimental infections 
induced by injection or immersion have been shown in pike (Esox lucius) and guppies 
(Poecilia sp). SVCV is not pathogenic for rainbow trout (Haenen, OLM, & A. Davidse 
1993) and goldfish (Carassius auratus) appear to be resistant to infection. 
Both juvenile and adult fish are susceptible to disease but once infected, fish are 
not subject to reinfection (Fijan et al. 1971; Wolf, 1988). Ambient water temperature 
plays an important role in the incubation and progression of the disease (Avtalion, R.R. 
1969; Cone, RE. & J.J. Marchalonis, 1972). Outbreaks of disease primarily occur during 
April through June when water temperatures are commonly between 11 and 17°C. It is 
thought that the lower water temperatures have a marked effect on antibody production, 
which increases the susceptibility to SVCV (Cone & Marchalonis, 1972). 
Clinical signs of fish affected with SVCV include exopthalmia, petechial 
hemorrhages of skin and gills, abdominal distention, and trailing pseudofecal casts 
(Fryer, J.L et al. 1996) 
Snakehead rhabdovirus 
SHRV was first isolated in 1986 from Snakehead fish (Ophicephalus striatus) in 
Thailand (Wattanavijarn, W. 1986). The virus is enzootic to Southeast Asia and is 
associated with, but is not necessarily the causative agent of an ulcerative disease in both 
wild and cultured Snakehead fish (Boonyaratpalin, S. 1989). Even though the 
rhabdovirus has been frequently isolated from snakehead that show clinical signs of the 15 
ulcerative disease, laboratory challenge with a characterized SHRV isolate did not induce 
disease (Frerichs et al. 1993). 
SHRV has bacilliform morphology, which is more characteristic of plant 
rhabdoviruses (Kasomchandra, J. et al. 1992). On the other hand, sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) protein profiles closely resemble that of 
IHNV, VHSV, HRRV, and rabies (Kasomchandra, J. et al. 1992). 
Rhabdovirus Glycoproteins 
The glycoproteins (G protein) of rhabdoviruses, are homotrimeric trans­
membrane-associated proteins that appear as spikes on the surface of the virion (Gaudin, 
Y. et a/.1992). These spikes are responsible for the initiation of infection, facilitate the 
fusion of the endocytic vesicle membrane with the viral envelope, and effect the process 
of budding and release of the virion by exocytosis (Burger, S.R. et al. 1991; Gaudin, Y. et 
a/.1992; Coll, J. 1997;Xiang, Z. et al. 1994). 
Glycosylation is important for proper folding, transport, and function of the G 
protein (Burger, S.R. et al. 1991). Synthesis of the G protein in the host cell follows the 
typical pathway of cellular membrane proteins via exocytosis. The addition of sugar 
moieties is N-linked and in rabies accounts for 10% of the final mass of the protein 
(Reading, C.L. et al. 1978). Failure to properly glycosylate the G protein inhibits 
transport to the plasma membrane of the infected cell. Rabies has three possible acceptor 
sites for glycosylation of which two are glycosylated (Wunner, W.H. et al. 1985). This 
pattern of glycosylation is typical of Rhabdoviruses. Studies on VSV indicate that 
glycosylation at both sites is necessary for transport (Bergmann, J.E. et al. 1981). In all 16 
rhabdoviruses studied, the basic structure of the G protein is highly conserved (Coll, J.M. 
1995). 
Rhabdoviral glycoproteins initiate infection 
Rhabdoviral glycoproteins act as the ligand that targets cell receptors foithe 
initiation of infection. Previous studies have shown that certain phospholipids inhibit the 
attachment function of rabies and VSV (Conti, C. et al. 1988; Mastromarino, P. et al. 
1987). The phospholipid, phosphatidylserine, strongly inhibits the attachment and 
infection of VSV and VHSV by binding to a site on the amino terminal end of the 
glycoprotein (Coll, J. 1997). The phosphatidylserine-binding domain has also been 
shown on the glycoproteins of IHNV as well. Studies on the rabies virus indicate that an 
amino acid substitution at arginine-333 of the glycoprotein abrogates virulence 
(Dietzschold et al. 1983), indicating that the glycoprotein is an important controlling 
factor for the initiation of infection. 
The effects of pH on Rhadboviral glycoprotein 
Rhabdovirus glycoproteins are profoundly affected by pH. In order for the virus 
nucleocapsid to enter the cytoplasm of the target cell, it is necessary for the virion to be 
endocytosed where the glycoprotein and membranes of the virion and the endocytic 
vesicle fuse. It is well established that this interaction is highly dependent on pH 
(Gaudin, Y. et al. 1995; Brown, J.C. et al. 1988). During acidification in the endocytic 
vesicle of a rabies infection, a pH  6 changes the conformation of the glycoprotein of 17 
rabies to an activated state, which initiates the fusion process (Gaudin, Y. et al. 1993; 
Konieczko, E.M. et al. 1994). Studies on VSV show that a lower pH aggregates the 
glycoproteins to the ends of the virion, which may be the preformed sites for the fusion 
process (Brown, J.C. et al. 1988). Unlike other viral families, the fusion properties of 
rhabdoviruses appear to be reversible where the loss of fusion activity at low pH can be 
reinstalled by bringing the pH to 7 (Gaudin, Y. et al. 1995). 
Rhabdoviral glycoproteins augment budding 
During the final stages of the replication cycle of rhabdoviruses, the 
transmembrane glycoprotein spikes target the host plasma membrane where the N-
terminus protrudes outside the membrane and the C-terminus is located on the inside as 
an anchor. Matrix proteins of the viral core target the glycoproteins in the plasma 
membrane and budding occurs (White, D.O., and F.J. Fenner 1994; Duffer, P. et al. 
1995). This process is called exocytotic budding. The induction of the budding process 
is totally dependent on the glycoproteins for hepadnaviruses and alphaviruses (Bruss, V. 
and D. Ganem 1991). The glycoprotein of rabies was also believed to have a similar role 
but in 1996 Mebatsion showed that the rabies virus was able to bud from infected cells in 
the absence of the spike glycoproteins (Mebatsion, T. et al. 1996). These studies 
indicated that the budding process of rhabdoviruses is not dependent on the presence of 
the glycoproteins. Even though the glycoproteins do augment the ability to bud, they are 
not absolutely dependent on the spike glycoproteins. Currently, it appears that the 
budding process for rhabdoviruses is more dependent on the interactions of the M protein 
of the virus with the plasma membrane proteins of the infected target cell. 18 
Viral glycoproteins induce neutralizing antibodies 
The glycoproteins of rhabdoviruses are also capable of stimulating an immune 
response in the organisms they infect. Glycoproteins of all rhabdoviruses, whose 
immuni7ation properties have been examined, are the only major structural protein that 
stimulates neutralizing antibodies (Benmansour, H. et al. 1991; Kelly, J. et al. 1972). 
Immunoblotting and enzyme-linked immunosorbant assays (ELISAs) of antisera from 
rainbow trout surviving an infection of IHNV show that these fish produce binding 
antibodies to the glycoprotein. They also produce neutralizing antibodies to the 
glycoprotein, which subsequently helps protect fish from the lethal effects of IHNV 
infections (Ristow, S.S. & J. Arnzen de Avila 1991; Lapatra, S. et al. 1993; Engelking, 
M. & J.C. Leong 1989). Similarly, rainbow trout injected with plasmid vectors 
containing the glycoprotein of IHNV generated glycoprotein specific antibodies that 
neutralized IHNV (Anderson, E.D. et al. 1996). Research on rabies also shows virus-
neutralizing antibodies to the rabies glycoprotein. When rabbits and mice are injected 
with a vaccinia-rabies glycoprotein recombinant virus, neutralizing antibodies in the sera 
are detected and these animals are protected from subsequent challenge of rabies (Wiktor, 
T. et al. 1984). In addition to neutralizing antibodies, research from Ertl's group has 
shown that intramuscular injection of a plasmid vector containing the glycoprotein gene 
of rabies in mice induces glycoprotein-specific cytolytic T-cells and lymphokine­
secreting T-helper cells (Xiang, Z. et al. 1994). The glycoprotein of VHSV is also the 
target of neutralizing antibodies in fish. Neutralizing antibodies specific for VHSV 
glycoprotein are detected from sera of rainbow trout that are injected intraperitoneally 19 
with a VHSV-glycoprotein recombinant subunit vaccine (Lecocq- Xhonneux, F. et al. 
1994). 
The glycoproteins of viruses also induce stimulation or inhibition of host cellular 
functions. When purified VSV glycoprotein is placed onto Syrian hamster kidney 
(BHK21-F) cell monolayers, an early inhibition of macromolecular synthesis was 
observed. Specifically, there was a decline in the incorporation of nucleosides into 
cellular DNA and RNA (McSharry, J.J. & P.W. Choppin 1978). Similarly, an inhibition 
of cellular RNA synthesis was observed in murine lymphoma cell lines (EL4) in the 
presence of isolated glycoproteins of disrupted mumps virus (Yamada, A. et al.  1984). 
Glycoproteins induce interferon 
As described earlier, interferon is an antiviral protein that is produced in animals 
and cells when there is a viral infection. It is well known that virus nucleic acid, 
especially double-stranded RNA, induce the production of interferon. Furthermore, 
studies mimicking virus nucleic acid by using synthetic homopolymers such as 
polyriboinosinic-polyribocytidylic acid (poly I:C), has confirmed the production of an 
interferon-like cytokine in fish (Congelton, J. & B. Sun, 1996; Eaton, W.D. 1990;). 
While dsRNA is the best-understood inducer of interferon, it has been shown that 
viral glycoproteins also induce interferon. Many studies by Yasuhiko Ito have described 
this phenomenon. In one experiment, mouse spleen cells that were cocultured with 
primary monkey kidney cells (PMK cells) infected with formaldehyde treated human 
parainfluenza type 4A (HPIV-4A) virus produced interferon. This finding suggests that a 
double-stranded RNA intermediate of virus infection was not required to induce 20 
interferon production. Similarly, a recombinant plasmid containing the sequence of 
hemagglutinin-neuraminidase (HN) glycoprotein transfected into COST cells and 
cocultured with mouse spleen cells produced interferon (Ito, Y. et al. 1994). In another 
experiment, Ito showed, in vitro, that contact of isolated HN glycoproteins of Sendai 
virus with the cell surface of mouse spleen cells stimulated the production of interferon. 
Each of these experiments provides evidence that viral glycoproteins are capable of 
stimulating lymphoid cells into synthesizing interferon. The model for this stimulation of 
interferon production is a membrane-membrane interaction between the lymphoid cells 
and the cells protruding glycoproteins. Ito proposes that virus glycoproteins act as lectins 
similar to concanavalin A and phytohemagglutinin, which have mitogenic properties that 
induce interferon in lymphoid cells (Ito, Y. 1994). 
Mx proteins 
One class of regulated proteins that are induced by interferon is the Mx proteins. 
All Mx proteins contain a conserved guanosine triphosphate (GTP)- binding domain, 
which is essential to their functional activity (Bourne, H.R. et al. 1991; Nakayama, M. et 
al. 1991; Pavlovic, J. et al. 1990). Located either in the nucleus or the cytoplasm, they 
appear to act directly by GTP- binding activity on the viral polymerase and/or indirectly 
by modifying cellular functions along the replication pathway of some viruses during an 
infection (Pavlovic, J. et al. 1993; Horisberger, M.A. 1995). In mice, the mRNA 
synthesis of influenza virus is inhibited by Mxl within the nucleus of infected cells 
(Staeheli, P. 1986). Similarly in humans, MxA proteins located in the cytoplasm inhibit 
the cytoplasmic replication steps of VSV at the transcription level (Horisberger, M.A. 21 
1992). The conferred resistance is thought to be the result of the direct interaction of 
GTPase activity on the viral polymerase (Pavlovic, J. et al.  1993). 
These proteins have also been shown to have intracellular anti-viral activity in 
other vertebrate cells. For example, expression of murine Mxl inhibits the 
orthomyxoviruses, Thogoto virus, and Dhori virus (Haller, 0. et al.  1995; Thimme, R. et 
a/. 1995). The MxA in humans has antiviral activity against bunyaviruses, phleboviruses, 
and hantaviruses (Frese, M. et al. 1996). Mx-like proteins have been identified in a 
number of vertebrates as well as fish (Rothman, J.H. et a/. 1990)(Trobridge, G.D. et al. 
1997). Our lab has previously described the presence of Mx proteins in rainbow trout 
injected with poly I:C. Under these conditions, the synthesis of Mx is induced following 
IHNV vaccination or infection. This induction could be an indicator that an interferon-
like protein is produced in fish. 22 
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Introduction 
The recent advances in DNA vaccine technology allows for a great strategy in the 
control of viruses that contain surface membrane glycoproteins. This type of vaccine 
involves the intramuscular injection of a bacterial plasmid containing a gene encoding a 
viral protein. This strategy enables eukaryotic processing of the protein as would 
naturally occur during a viral infection. The advantage of DNA vaccines is the 
stimulation of both humoral and cellular immune responses (Donnelly, et al. 1997). 
DNA vaccines not only induce the production of antibodies but also stimulate cytotoxic T 
cells and helper T cells, which can be regarded as necessary components of a truly 
effective vaccine (Leung, K.N. & G.L. Ada, 1982; Taylor, P.M. & B.A. Askonas, 1986). 
There have been many recent studies that show glycoprotein based DNA vaccines 
stimulate these kinds of immune responses in the hosts that receive them (Anderson, E.D. 
et cd.1996; McClements, W.L. et al. 1996; Xiang, Z.Q. et al. 1994; Manickan, E. et al. 
1995; Xu, D. & F.Y. Liew, 1995; Cox, G.J.M. et al. 1993; Bourne, N. et al. 1996). 
Our lab has developed a glycoprotein based DNA vaccine for rainbow trout 
against IHNV (Anderson, E.D. et al. 1996). Immunization experiments followed by 
IHNV challenge produced relative survival rates of 75 percent or greater, even in fish as 
small as 0.3-0.4 g average weight. These findings were very encouraging and we 
assumed that protection was specific for IHNV. Earlier studies by Anderson et al. 1996 
had shown that fish injected with the DNA vaccine do produce neutralizing antibodies to 
IHNV at eight weeks post vaccination. However, Yasulnico Ito had shown that viral 
glycoproteins could stimulate the production of interferon, which could be the basis for 
the protection. According to Ito, viral glycoproteins, in general, can act as a mitogen to 24 
stimulate lymphoid cells into producing interferon. This stimulation is based on a 
membrane-membrane interaction between the lymphoid cell and the cell containing the 
protruding transmembrane glycoprotein (Ito, Y. 1994; Ito, Y. et al. 1994; Ito, Y. & Y. 
Hosaka, 1983). We sought to examine the specificity of the IHNV response induced by 
the IHNV DNA vaccine by treating fish with several different plasmid vectors containing 
glycoprotein genes from different rhabdoviruses. 
In this study, we present evidence that glycoprotein based DNA vaccines injected 
into rainbow trout induce an immune response which is similar to that described by Ito. 
All of the tested glycoprotein vaccines provided non-specific protection against IHNV 
infection. Plasmid DNA encoding the glycoproteins of IHNV (pcDNA3-IHNV-g), 
SHRV (pcDNA3-SHRV-g), or SVCV (pcDNA3-SVCV-g) was injected into the skeletal 
muscle of rainbow trout fry. After 30 days, the fish were challenged with IHNV. Results 
clearly indicate that the glycoproteins of these different viruses all induced a protective 
immune response in fish. The mechanisms for the viral mediated resistance induced by 
these DNA vaccines is unknown, but a parallel study conducted by Dr. Carol Kim, who 
examined the production of Mx proteins in these fish, suggests that the non-specific 
protection observed might be a consequence of the stimulation of interferon. 25 
Materials and Methods 
Cell line and virus 
The chinook salmon embryo (CHSE-214) cell line was obtained from J.L. Fryer, 
Oregon State University, Corvallis. These cells were propagated in minimum essential 
medium (MEM) supplemented with 10% fetal bovine serum, 1% antibiotic-antimycotic 
(GibcoBRL; 10,000 units/ml penicillin G sodium and 10,000 µg/ml streptomycin sulfate 
and 25 µg/ml of amphotericin B), 1% 200 mM L-glutamine, and buffered with 7.5% 
sodium bicarbonate to pH 7.4. 
The IHNV isolate (IHNV-RA) used in this study was obtained from Rangen 
Research Laboratories, Idaho, USA. Virus was propagated in CHSE-214 cells grown in a 
ten-layer cell factory (Nunc Company) at a multiplicity of infection of 0.01 at 16°C. At 
Day 7 complete cytolytic effect (CPE) was confirmed by microscopy and the culture 
fluid was harvested and centrifuged in a sorvall GS-3 rotor at 10,825 x g for 30 minutes 
at 4°C. The Supernatant was then filtered through a 0.2 gm bottle top filter (Schleicher 
& schvell), alloquoted, and stored in -80°C. 
Plaque assay 
Virus titer was determined by plaque assay (Burke, J.A. and D. Mulcahy 1980). 
A sub sample taken from -80°C was thawed and 10 fold serial dilutions were performed 
in MEM media. Dilutions were plated onto CHSE-214 monolayers in six well plates and 
incubated for one hour by hand rocking the plates every ten minutes. After incubation, 3 26 
mis of methylcellulose were placed over the monolayers and incubated for 10 days in 6% 
CO2 at 16°C. At day 10, cell monolayers were fixed and stained with crystal violet in 
formalin (25% formalin, 10% ethanol, 5% acetic acid, 1% w/v crystal violet) for 24 
hours. Cell monolayers that contained between 25-250 plaques were used to determine 
virus titer. IHNV-RA strain was determined to be 1.24 x 108 pfu/ml. 
Plasmid constructs 
Plasmid vectors encoding the glycoprotein gene sequences of IHNV, SHRV, and 
SVCV were constructed for this experiment. All of these glycoprotein gene sequences 
were previously cloned in our laboratory. The gene for the glycoprotein of IHNV 
(IHNV-g) was originally cloned into the plasmid pCMV. The glycoprotein genes of 
SHRV (SHRV-g) and SVCV (SVCV-g) were originally cloned into the plasmid 
pcDNA3. IHNV-g was removed from pCMV by restriction enzyme digest and inserted 
into pcDNA3 by ligation. DNA sequencing of the first 400 nucleotides verified correct 
nucleotide sequence and orientation. In vitro translation of the plasmids pcDNA3-IIINV­
g, pcDNA3-SHRV-g, and pcDNA3-SVCV-g determined the correct protein product. 
Amino acid sequence analysis 
Glycoprotein amino acid sequences of IHNV, SHRV, and SVCV were compared 
for homology. The sequences were imported into a genetic data environment where the 
initial amino acid alignments were created using CLUSTAL. Conserved amino acids 27 
were identified among these three glycoproteins and were used to determine percent 
amino acid identity. 
Purification of plasmids 
The resulting Plasmids, pcDNA3, pcDNA3-IHNV-g, pcDNA3-SHRV-g, and 
pcDNA3-SVCV-g were grown in transformed Escherichia coli, JM109 competent cell 
strain, in the presence of Ampicillin. Using the Qiagen purification plasmid kit according 
to the manufacturer's protocol, large-scale purification of each plasmid was performed. 
The concentration of purified plasmids was determined by optical density (OD) at 260 
nm. 
Plasmid injection of rainbow trout 
Rainbow trout used in this research were a cross between Klamath strain 
(Klamath hatchery, Oregon) and Cape cod strain (Roaring river hatchery, Oregon). Both 
strains were spawned at their corresponding hatcheries and then fertilized at the Oregon 
State University, Salmon Disease Laboratory, Corvallis, Oregon. Fry were held in 100 
liter tanks until fish mean weight was 0.5 grams. 
The previously described plasmids, pcDNA3-IHNV-g, pcDNA3-SHRV-g, 
pcDNA3-SVCV-g, pcDNA3 and phosphate saline buffer (PBS) were used in the 
injection. Plasmid DNA concentrations were adjusted to 10 jAg/251.11 by diluting in PBS, 
pH 7.4 and confirmed by spectrophotometry. Five groups of 200 fish (.56 grams mean 
wt) per group were anesthetized in 0.1% Tricane methanesulfonate (MS-222, Finquel) 28 
and injected intramuscularly with the corresponding plasmid or PBS and placed in 25 
liter tanks, 50 fish per tank. A total of twenty tanks were used: four for pcDNA3, four for 
pcDNA3-IHNV-g, four for pcDNA3-SHRV-g, four for pcDNA3-SVCV-g, and four for 
PBS injected fish. Tanks were interspersed amongst each other to eliminate possible tank 
effects. The injection of PBS was the positive control for the injection procedure and the 
injection of pcDNA3 was the negative control of the immune response to the plasmid 
without the glycoprotein insert. 
Challenge of Rainbow trout to IHNV 
At 30 days post injection fish were challenged, by immersion, with IHNV-RA 
strain. Mean fish weight was 1.33g. Fish were challenged with two viral doses: 103 and 
105 pfu/ml. In both challenge doses, two tanks (fifty fish per tank) of each group were 
exposed to IHNV-RA in two liters of water at 15°C for 5 hrs. Post-challenge fish 
mortality from each tank was removed and recorded daily for 30 days. 29 
Results 
Plasmid Construction 
The different plasmids used in the study are shown in Figure 1. Each plasmid 
contains a glycoprotein gene from each of three rhabdoviruses. The plasmid pcDNA3­
IHNV-g contains the gene encoding 1HNV glycoprotein. Similarly, the plasmid 
pcDNA3-SHRV-g contains the gene encoding SHRV glycoprotein and pcDNA3-SVCV­
g contains the gene encoding SVCV glycoprotein. 
DNA sequence analysis, restriction enzyme analysis, and in vitro translation 
confirmed each plasmid construct. The sizes of the proteins produced by in vitro 
translation correlate well with the expected size for a non-glycosylated protein for each 
plasmid (Figure 2). These findings indicated that the viral glycoprotein genes used in the 
study were complete, in the correct orientation, and contained no nucleotide sequence 
changes. 30 
Figure 1. Plasmid vectors encoding the glycoprotein gene sequences of IHNV, SHRV 
and SVCV. Restriction enzymes used in ligation and analysis are shown. 31 
Figure 1. 
Plasmid vectors containing viral glycoprotein DNA sequences 
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Figure 2. Autoradiograph of the proteins produced in vitro translation reactions of RNA 
synthesized from pcDNA3-IHNV-g, pcDNA3-SHRV-g, and pcDNA3-SVCV­
g. The glycoproteins were produced using TNT® coupled reticulocyte lysate 
system. T7 polymerase was used to drive transcription from the T7 promoter. 
The proteins synthesized off those transcripts were labeled by incorporating 
[35S] methionine. Products were electrophoresed on a 10% denaturing SDS 
PAGE gel. Lane 1, pcDNA3-IHNV-g, lane 2, pcDNA3-SHRV-g, and lane 3, 
pcDNA3-SVCV-g. Molecular weights for the glycoproteins of IHNV, SHRV, 
and SVCV correlate well with the expected size for non-glycosylated g-
proteins. (Autoradiograph Performed by Marc Johnson, 1998) 33 
Figure 2. 
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Glycoprotein amino acid sequence analysis 
Glycoprotein amino acid sequence analysis of MNV, SHRV, and SVCV were 
aligned with each other to determine homology. The alignment shows that there are no 
large conserved amino acid motifs among the three glycoproteins (Table 1). 
Furthermore, only a single motif exists in which three consecutive amino acids are 
conserved. A total of 61 sites of a possible 560 are identical between the three 
glycoproteins, resulting in an eleven percent amino acid identity. 35 
Table 1 Amino acid sequence analysis of the glycoproteins of IIHNV, SHRV, and 
SVCV. Proteins were aligned using CLUSTAL (GDE version 2.1) protein 
alignment program. Highlighted, are the amino acids conserved among all 
three proteins. 36 
Table 1. 
Amino acid sequence analysis of the glycoproteins used in this study 
SVCV- RSIIS  YIAALLIDSNLGIPIFVPSGR  NISWQPVIQPFDYcL4PIH--­
SHRV- MTLPNMKPKRIVLAVFLNAWVSNAQVTHKPRPDSIVEYSE-E*ENPIYTTPSHtFEDTFA
 
IHNV- TCGANSQTVKPDTASESDQPTWSNPLFTYPEGTLDKLS
 
4
 
SVCV- ----GNLP  NT  SATKLTKSPSVFSTD---KVSWICAAAEWKTTaDYRWYE
 
iJ+,  ?b 
SHRV- PVKPEKLRCPHIFDDQN  TASKAKXLHMDLKPEDTHFEAKPRLLpKVTYQVLPSTGFF0
 
IHNV- KVNASQLRCPRIFDDENR  IAYPTSRSLSVGNDLGDIHTQONHIKVLYRTIOSTGFF0
 
11
 
SVCV- PQYITHSIHPISPTIDICRRIIQRIASGTDEDLIPPQS77GOASVTTVSNTNYR-VVPHSi
 
SHRV- GRTVTRKVLETPMGDNO----AQAYKAVDREFPYOEPLOF*LRDNVAAERVFHFSTPKTY
 
IHNV- GQTIEKALVEMKLST4----AGAYDTTTAAALYOPAPROO4YTDNVQNDLIFYYTTQKS#
 
17
 
SVCV- HLEqGGHWIDHEi3  EaREKV7dEMKGNHSI#ITEETVQHEAKHIEEVEGIMYGNVPRG
 
SHRV- TVDLSRKYISP'  AKSPOPTHWPNVYJOGETQSP-EgPS-IDTEGGHIFTKKDTH
 
IHNV- LRDP*TRDFLDSDE  TKSPOQTHWSNVV$MGDAGIP-AODS-SQEIKGHLFVDKISN
 
25
 
SVCV- DVMYANNFIIDRHRVYRFGGSQMKtONKDGIKFARGDOVEKTATTTIHDO
 
, ­
SHRV- RITKAVVH----G0HPWGLTKAWIqcNEQ  WIRTDI4DtIRIEPODGTSSLT
 
IHNV- RVVKATSY----GOHPWGLHQAMIEfOGKQ  WIRTDLGDLISVEYNSGAEILS
 
33
 
SVCV- VWVDGTLVSGHRPG00----t?IDTVFNLENVVtYTLEGTKREINKQEKLTSVDt*LA
 
SHRV- T44#KENVV--QMRGN4DFPYLNHAIVNMAQRS---PLEAHSSIVAQQKVSPYLOKFR
 
IHNV- FOOOEDKTV--GMRGNODFAYLDDLVKASESREE---lcLEAHAEIISTNSVTPY4$KFR
 
44
 
SVCV- PRIG&FGSVFRVRNGTLER'OSTTYIRIEVEGPIVDSLNGTDPRTNASRVFWDDOELD-GNI
 
SHRV- PPHPOLGKAHYLQNNTIMR0--DCIYEGVAEISENRTTYRNLKGE  WKKWSLSRGGK
 
IHNV- SPHPOINDVYAMHKGSIYg0--MCMTVAVDEVSKDRTTYRAHRATS  FTKWERPFGDE
 
48
 
SVCV- YQTGFNVYKGKDGKIHtLNMIESGIIDDELQHAFQADIIPHPH----YDDDEIREDDtFF
 
SHRV- --GYDGMTVGN--KIVODLEKYQSIYDNGMFIPKLLGEVPHRSIVITYNQTDSIETGtF­
-
 IHNV- WEGFHGLHGNN--TTItPDLEKYVAQYKTSMMEPMSIKSVHPSILALYNETDVSGISTR­
57
 37 
SVCV­ DNTGENGNPVDAVVEWVS4GTSLKFFGMTLVALILI FLLI ROTCVACTYLMKRSKRPATES 
SHRV­ T DGKLLNMGV4- TLOPS --LSGI SLFTVASLI L IWYOOC-- -RVT PQALNYS I PM 
I HNV­ ----KLDSFDLQSLHg-S F*PT­ I SALGGI PFALLLAVAAcCCWSGRRRT PSASQS I PM 
61 
SVCV­ HEM- -RSL-V 
SHRV­ HT I TSRGVE I 
I HNV­ YHLANRS--­
61 
Total alignment between the three glycoproteins = 61 
560 amino acids  :  61 alignments 
(61/560) x 100 = 11% alignment relationship 38 
Effect of DNA immunization against challenge to IHNV 
Immunized and control (PBS and pcDNA3) fish were challenged by immersion in 
water containing different concentrations of IHNV (Rangen isolate). The fish were 
observed daily for signs of disease and dead individuals were removed. Figure 3 shows 
the effect of pcDNA3-IHNV-g, pcDNA3-SHRV-g, or pcDNA3-SVCV-g immunization 
on survival against a challenge dose of 105 pfu/ml. Significant protection was observed 
with relative percent survivals of 93.2% (pcDNA3-IHNV-g), 98.3% (pcDNA3-SHRV-g), 
and 94.9% (pcDNA3-SVCV-g) (Table 2). The control fish that received either PBS or 
pcDNA3 had percent cumulative mortalities of 55% and 57%, respectively. The results 
observed for fish challenged with 103 pfu/ml are similar to that observed at 105 pfu/ml, 
i.e. all glycoprotein-vaccinated fish were protected as compared to the controls (Figure 
4). As expected, the mortalities that were observed in the 103 pfu/ml challenge dose was 
lower (Table 3). 39 
Figure 3. The effect of intramuscular DNA immunization on survival against IHNV (105 
pfu/ml). DNA vaccines consisted of pcDNA3-IHNV-g, pcDNA3-SHRV-g, 
and pcDNA3-SVCV-g. Trout in the control groups were injected with PBS and 
pcDNA3. 40 
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Figure 3: Percent cumulative mortality of fish injected with DNA and challenged with 
IHNV (10'15 pfulml) 
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Table 2. Survival of fish challenged with IIINV (105 pfu/ml) after injection with plasmid 
DNA. 100 fish per group was obtained by the sum of 50 fish in duplicate for 
each treatment. Dead fish were removed from each tank and recorded daily 
for cumulative mortality results. Percent cumulative mortality is based on the 
100 fish from both tanks (50 per tank) for each treatment group. 42 
Table 2. Survival of fish challenged with IHNV (105 pfu/ml) after injection with plasmid 
DNA. 
No. of fish  Total no.  % Cumulative 
Treatment  per group  of deaths  mortality  RPS* 
PBS  100  56  56 
pcDNA3  100  59  59 
pcDNA3-IHNV-g  100  4  4  93.2 
pcDNA3-SHRV-g  100  1  1  98.3 
pcDNA3-SVCV-g  100  3  3  94.9 
Fish (mean wt .5g) were injected the phosphate-buffered saline (PBS) or each respective plasmid as
 
indicated. 30 days after injection, fish (mean wt. 1.13g) were challenged with 105 pfu/liter of IHNV
 
(Ranger). The challenge trial was conducted for 30 days.
 
*RPS indicates relative percent survival, calculated as described by Johnson et al. (1982):
 
RPS = [1-(% mortality of vaccinated fish/ % mortality of control fish, pcDNA3)] x 100. 43 
Figure 4. The effect of intramuscular DNA immunization on survival against IBNV (103 
pfu/ml). DNA vaccines consisted of pcDNA3-IFINV-g, pcDNA3-SHRV-g, 
and pcDNA3-SVCV-g. Trout in the control groups were injected with PBS and 
pcDNA3. 44 
Figure 4: Percent cumulative mortality of fish injected with DNA and challenged with 
IHNV (10"3PFU/ML) 
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Table 3. Survival of fish challenged with IHNV (103 pfu/ml) after injection with plasmid 
DNA. 100 fish per group was obtained by the sum of 50 fish in duplicate for 
each treatment. Dead fish were removed from each tank and recorded daily for 
cumulative mortality results. Percent cumulative mortality is based on the 100 
fish from both tanks (50 per tank) for each treatment group. 46 
Table 3. Survival of fish challenged with IHNV (103 pfu/ml) after injection with plasmid 
DNA. 
No. of fish  Total no.  % Cumulative 
Treatment  per group  of deaths  mortality  RPS 
PBS  100  33  33 
pcDNA3  100  16  16 
pcDNA3-IHNV-g  100  0  0  100 
pcDNA3-SHRV-g  100  1  1  93.8 
pcDNA3-SVCV-g  100  2  2  87.5 
Fish (mean wt .5g) were injected the phosphate-buffered saline (PBS) or each respective plasmid as
 
indicated. 30 days after injection, fish (mean wt. 1.13g) were challenged with 103 pfu/liter of IHNV
 
(Rangen). The challenge trial was conducted for 30 days.
 
*RPS indicates relative percent survival, calculated as described by Johnson et al. (1982):
 
RPS = [14% mortality of vaccinated fish/ % mortality of control fish, pcDNA3)] a 100. 47 
Summary of statistical fmdings 
In the challenge dose of 105 pfu/ml, there is strong evidence that the mean 
mortalities of fish in the DNA vaccinated groups differ from that of the PBS control 
group (two-sided p-value < .0001, t-test). Conversely, There is no evidence that the 
mortalities of fish in the pcDNA3 control group are different from that of the PBS control 
group (two-sided p-value = .30, t-test). 
In the challenge dose of 103 pfu/ml, there is similar evidence that mortalities 
between the DNA vaccinated groups and the PBS control group are different (two-sided 
p-value < .001, t-test). However, there is no evidence that the PBS control group and the 
pcDNA3 control group are the same (two-sided p-value < .001, t-test). All statistical 
findings were based on the comparison of means using a pooled estimate of the standard 
deviation and five degrees of freedom (Table 4 and Table 5). 48 
Table 4. Data from fish challenge dose 105 pfu/ml used to derive statistical significance 
between treatment groups. The data represents the actual mortalities in each 
tank. 49 
Table 4. Data for statistical findings for Challenge dose 105 pfu/ml. 
Average mortalities  Standard 
Treatment group  fish per tank  Mortalities  within group  deviation 
PBS  50  30  28  2.83 
PBS  50  26 
pcDNA3  50  30  29.5  0.71 
pcDNA3  50  29 
pcDNA3-IHNV-g  50  2  2  0 
pcDNA3- IHNV -g  50  2 
pcDNA3-SHRV-g  50  0  0.5  0.71 
pcDNA3-SHRV-g  50  1 
pcDNA3-SVCV-g  50  2  1  0.71 
pcDNA3-SVCV-g  50  1 
Pooled estimate of the standard deviation (Sp) = 1.90 
Sp2 = Rni-1)s12+ (n2-1)s22 +  + (n1-1)s][2]/ Kni-1) + (n2-1) +  + (n1-1)] 
Degrees of freedom = 5 50 
Table 5. Data from fish challenge dose 103 pfu/ml used to derive statistical significance 
between treatment groups. The data represents the actual mortalities in each 
tank. 51 
Table 5. Data for statistical findings for Challenge dose 103 pfu/ml. 
Average mortalities  Standard 
Treatment group  fish per tank  Mortalities  within group  deviation 
PBS  50  18  16.5  2.12 
PBS  50  15 
pcDNA3 50 8  8  0 
pcDNA3  50  8 
pcDNA3-IHNV-g  50  0  0  0 
pcDNA3-IHNV-g  50  0 
pcDNA3-SHRV-g  50  0  0.5  0.71 
pcDNA3-SHRV-g  50  1 
pcDNA3-SVCV-g  50  2  1  1.41 
pcDNA3-SVCV-g  50  0 
Pooled estimate of the standard deviation (Sp) = 1.40 
Sp2 = [(n1-1)s12 + (n2-1)s22 + ... + (ni-1)0/ Rni -1) + (n2-1) + ... + (n-1)] 
Degrees of freedom = 5 52 
Discussion 
In this study, we show that DNA vaccines encoding the glycoproteins from 
different fish viruses stimulate a protective immune response to IHNV challenge. 
Injection of plasmid vectors containing the glycoprotein gene sequences of IHNV 
(pcDNA3-IHNV-g), SHRV (pcDNA3-SHRV-g), or SVCV (pcDNA3-SVCV-g) into the 
skeletal muscle of rainbow trout induced protection against an IHNV lethal challenge. 
The viral glycoproteins used in this experiment belong to viruses that are 
members of the family Rhabdoviridae, and are serologically distinct Amino acid 
sequence identity indicates that SVCV is similar to vesicular stomatitis virus (VSV), 
which is the prototype virus of the Vesiculovirus genus (Bjorklund, H.V. et al. 1996). 
The protein profile of IHNV is more similar to the Novirhabdovirus genus (Bjorklund, 
H.V. et al. 1996). Sequence homology for the SHRV glycoprotein also indicates that this 
virus is a member of the Novirhabdovirus genus, but is distinct from IHNV (Johnson, M. 
unpublished results, 1997). In addition to these differences in protein structure, cross 
neutralization experiments show that these viruses are not related serologically. Eight fish 
rhabdoviruses were examined for cross neutralization (Kasomchandra, J. et al. 1992). 
These tests using polyclonal antibodies derived from mice and rabbits injected with 
IHNV, SHRV, and SVCV, were negative according to the alpha method of Rovozzo and 
Burke (Rovozzo, G.C. and C.N. Burke 1973). 
The non-specific protection observed in these fish could be attributed to the 
production of interferon by immune cells such as macrophages and nonspecific cytotoxic 
cells or by other lymphoid cells. When a DNA vaccine is injected into the skeletal muscle 
of fish, the plasmid DNA is delivered inside the cells by a mechanism that is still 53 
unknown. Once inside the cell, the cDNA of the viral glycoproteins, gets transcribed, 
translated, glycosylated, and then transported to the plasma membrane. The 
glycoproteins protrude through the membrane, comparable to a normal viral infection, 
and are detected by an immune cell (Figure 5). Ito's hypothesis is that lymphoid cells 
detect these glycoproteins by membrane-membrane interactions and produce interferon 
(Ito, Y. 1994). Thus, the rainbow trout injected with the glycoprotein based DNA 
vaccines thirty days prior to virus challenge remain in an antiviral state upon challenge 
with IHNV or possibly any other virus. Subsequently, these fish became less susceptible 
to the lethal effects of virus infection. Production of a Mx protein was observed in a 
parallel study of these fish conducted by Dr. Carol Kim. Preliminary results showed that 
Mx was detected in fish injected with the DNA vaccines but not in the control fish (data 
not published). Mx is an interferon-regulated protein that is stimulated by the induction of 
interferon in mammals (Staeheli, P. 1990; Sammuel, C.E. 1991). Collectively, these 
observations support Ito's model that glycoproteins induce interferon synthesis. 
There are many arms of the immune system in fish and undoubtedly there is a 
specific immune response to the glycoproteins, which would induce neutralizing 
antibodies specific for epitopes on the glycoproteins. One could imagine that either the 
plasmid vectors themselves are transfected into macrophages or alternatively, that the 
glycoproteins are phagocytosed and processed. Either would be presented in the context 
of MHC class II for the stimulation of antibody production. Previous experiments using 
the glycoprotein of IHNV as a DNA vaccine provides evidence that neutralizing 
antibodies are produced (Anderson, E.D. et al. 1996). In addition to the detection of Mx 
in the treatment groups upon injection, the very opposite occurs in fish vaccinated with 54 
pcDNA3- IHNV -g upon challenge with IHNV. The loss of the ability to detect Mx in this 
group might be accountable by the stimulation of other arms of the immune system 
leading to neutralizing antibodies and cytotoxic cells. With the stimulation of interferon 
production as the first line of defense against virus infection, followed by the synthesis of 
antibodies specific for the IHNV glycoprotein and the activation of cytotoxic T cells, the 
virus is cleared before the infection process can be amplified. Roers et al. 1994 studying 
the induction of Mx proteins in vaccinated and unvaccinated individuals upon infection 
with the 17-D strain of yellow virus, reported that unvaccinated individuals produced 50­
fold more Mx protein than vaccinated individuals. They suggested that the vaccinated 
individuals had enough circulating antibody to clear the virus before interferon was 
induced. The same model might account for the clearance of IHNV in fish injected with 
pcDNA3-IHNV -g. The virus is reproductively inhibited by interferon, neutralized and 
opsonized by antibodies, and cytotoxic T cells destroy infected cells leading to virus 
clearance. However, the fish vaccinated with pcDNA3- SHRV -g and pcDNA3-SVCV-g 
most likely produced specific immune responses against their respective glycoproteins, 
which may not have influenced the protection against IHNV that was observed. 
Virus-specific immune responses other than neutralizing antibodies also provide 
protection. Xiang, et al. 1994, has characterized the protective immunity in mice 
vaccinated against rabies with a plasmid vector carrying the rabies glycoprotein. This 
study showed that cytotoxic T leukocytes were activated specifically to the rabies 
glycoprotein expressed by target cells in the context of MHC class I (Xiang, Z.Q. 1994). 
Although specific immune responses have been observed for rabies, there may still be an 
alternative explanation for protection. Xiang, Z.Q. 1994, did not consider non-specific 55 
immune factors. We show in this report that all three unrelated viral glycoproteins 
induced protection to IHNV and that the DNA induced a non-specific protective 
response. 
Although numerous questions remain to be answered about the specific 
mechanisms that are involved with the induction of the observed protection, this study 
has shown that non-specific, non-humoral protective immune responses in rainbow trout 
plays an important role in controlling an IHNV infection. Understanding the relationship 
between viral glycoproteins and the stimulation of a non-specific immune response will 
provide important information for the development of vaccines in rainbow trout fry, 
which will focus on cell-mediated immunity. It is generally accepted that the humoral 
response in trout fry is relatively poor or non-existent and is not the controlling factor 
leading to protection. This study reinforces the notion that glycoprotein based DNA 
vaccines stimulate non-specific immune responses, which leads to sufficient protection 
during the time when trout fry are most susceptible to IHNV. The use of this technology 
will improve our understanding of the immune system of trout, viral pathogenesis of 
IHNV, and may subsequently improve the development of vaccines. 56 
Figure 5. Proposed illustration on the pathway of glycoprotein based DNA vaccines 
leading to the stimulation of interferon by a lymphoid cell. When the DNA 
vaccine is injected into the muscle of trout, the plasmids are transfected into 
muscle cells. This results in the production of transmembrane glycoproteins 
and a membrane-membrane interaction between the lymphoid cell and the 
muscle cell containing the protruding glycoproteins. 57 
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CHAPTER 4
 
SUMMARY
 
Intramuscular injection of glycoprotein-based DNA vaccines into rainbow trout 
induces protective immunity against an IHNV lethal challenge. This study shows that the 
different plasmid vectors encoding the gene sequences of serologically distinct 
glycoproteins from different fish rhabdoviruses all protect trout fry against IHNV. The 
differences between the DNA vaccinated treatment groups and the control groups are 
statistically significant and clearly show that some kind of protection mechanism is 
induced by the DNA vaccines. Although the exact mechanism is unknown, this study 
coupled with the additional studies by Dr. Kim suggest that interferon may be 
contributing to the protective immune response. Collectively, these two studies suggest 
that the model developed by Ito regarding the synthesis of interferon by viral 
glycoproteins can be applied to teleost systems as well. 
Undoubtedly, this study presents an important finding in understanding the of 
immune response in fish and much more research will have to be done in characterizing 
the mechanism(s) involved with this type of observed protection. Cloning of trout 
interferon will be a major advancement for this type of research. Once cloned, research 
can be directed to how interferon is stimulated, how much interferon is needed to 
ascertain biochemical functions leading to protection, and what other components of a 
viral infection leads to the production of interferon. 
Even though there are important differences between the immune response in 
fish versus mammals, much of the immune components and functions are similar. In 
mammalian and teleost systems, the paradigm in developing vaccines for controlling viral 59 
pathogens has been focused on stimulating the humoral immune response for the 
production of neutralizing antibodies. Within the last decade, researchers have come to 
an understanding that although neutralizing antibodies play an important role, a truly 
effective vaccine also needs to induce the cellular-mediated immune response, especially 
during the early stages of an infection. The results of this study are not only important in 
furthering our understanding of the trout immune system, but also provides the 
development of a future vaccine strategy for the use in trout aquaculture. In these high 
density-rearing facilities, fish at early life stages are most susceptible to viral pathogens 
and mortality can be extremely high. It is generally accepted that the humoral response 
in trout fry is relatively poor or non-existent. Thus, the development of a vaccine that 
stimulates other arms of the immune system that leads to protection is of great 
importance. 60 
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